The story of Sildenafil presents a interesting case for investors in the drug sector. While initially a phenomenal success, generating billions, the patent lapse and the subsequent arrival of off-brand competitors have https://knockoff264425.blogstival.com/63392939/viagra-and-pharma-a-risky-investment